These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
427 related articles for article (PubMed ID: 26805203)
1. [Combination Chemotherapy Using Sorafenib and Hepatic Arterial Infusion with a Fine-Powder Formulation of Cisplatin for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis--A Case Report]. Tsukamoto T; Kanazawa A; Shimizu S; Murata A; Sakae M; Kurihara S; Tashima T; Deguchi S; Nakai T; Kawasaki Y; Kioka K Gan To Kagaku Ryoho; 2015 Nov; 42(12):1878-80. PubMed ID: 26805203 [TBL] [Abstract][Full Text] [Related]
2. [A case of curative resection for advanced hepatocellular carcinoma with portal vein tumor thrombus after hepatic arterial infusion chemotherapy]. Ishizaki M; Kaibori M; Matsui K; Nakatake R; Matsushima H; Sakaguchi T; Kwon AH Gan To Kagaku Ryoho; 2012 Nov; 39(12):1991-3. PubMed ID: 23267953 [TBL] [Abstract][Full Text] [Related]
3. A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Song DS; Song MJ; Bae SH; Chung WJ; Jang JY; Kim YS; Lee SH; Park JY; Yim HJ; Cho SB; Park SY; Yang JM J Gastroenterol; 2015 Apr; 50(4):445-54. PubMed ID: 25027973 [TBL] [Abstract][Full Text] [Related]
4. Randomized, prospective, comparative study on the effects and safety of sorafenib vs. hepatic arterial infusion chemotherapy in patients with advanced hepatocellular carcinoma with portal vein tumor thrombosis. Choi JH; Chung WJ; Bae SH; Song DS; Song MJ; Kim YS; Yim HJ; Jung YK; Suh SJ; Park JY; Kim DY; Kim SU; Cho SB Cancer Chemother Pharmacol; 2018 Sep; 82(3):469-478. PubMed ID: 29982870 [TBL] [Abstract][Full Text] [Related]
6. Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy Combined with Radiotherapy and Sorafenib for Advanced Hepatocellular Carcinoma Patients with Major Portal Vein Tumor Thrombosis. Kodama K; Kawaoka T; Aikata H; Uchikawa S; Nishida Y; Inagaki Y; Hatooka M; Morio K; Nakahara T; Murakami E; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Masaki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Kimura T; Nagata Y; Chayama K Oncology; 2018; 94(4):215-222. PubMed ID: 29428943 [TBL] [Abstract][Full Text] [Related]
7. Phase II Study of Sorafenib Combined with Concurrent Hepatic Arterial Infusion of Oxaliplatin, 5-Fluorouracil and Leucovorin for Unresectable Hepatocellular Carcinoma with Major Portal Vein Thrombosis. He MK; Zou RH; Li QJ; Zhou ZG; Shen JX; Zhang YF; Yu ZS; Xu L; Shi M Cardiovasc Intervent Radiol; 2018 May; 41(5):734-743. PubMed ID: 29327075 [TBL] [Abstract][Full Text] [Related]
8. [The effect of sorafenib and intermittent hepatic arterial infusion chemotherapy using cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombus--a pilot study]. Ishizaki M; Kaibori M; Matsui K; Yanagimoto Y; Nakatake R; Kwon AH Gan To Kagaku Ryoho; 2010 Nov; 37(12):2679-82. PubMed ID: 21224678 [TBL] [Abstract][Full Text] [Related]
9. Hepatic arterial infusion therapy with a fine powder formulation of cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis. Kondo M; Morimoto M; Numata K; Nozaki A; Tanaka K Jpn J Clin Oncol; 2011 Jan; 41(1):69-75. PubMed ID: 20688778 [TBL] [Abstract][Full Text] [Related]
10. Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: analysis of 48 cases. Ando E; Tanaka M; Yamashita F; Kuromatsu R; Yutani S; Fukumori K; Sumie S; Yano Y; Okuda K; Sata M Cancer; 2002 Aug; 95(3):588-95. PubMed ID: 12209752 [TBL] [Abstract][Full Text] [Related]
11. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis. Hu J; Bao Q; Cao G; Zhu X; Yang R; Ji X; Xu L; Zheng K; Li W; Xing B; Wang X Cardiovasc Intervent Radiol; 2020 Jul; 43(7):996-1005. PubMed ID: 31974744 [TBL] [Abstract][Full Text] [Related]
12. Hepatic arterial infusion chemotherapy in hepatocellular carcinoma with portal vein tumor thrombosis. Song DS; Bae SH; Song MJ; Lee SW; Kim HY; Lee YJ; Oh JS; Chun HJ; Lee HG; Choi JY; Yoon SK World J Gastroenterol; 2013 Aug; 19(29):4679-88. PubMed ID: 23922465 [TBL] [Abstract][Full Text] [Related]
13. Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis. Lai YC; Shih CY; Jeng CM; Yang SS; Hu JT; Sung YC; Liu HT; Hou SM; Wu CH; Chen TK World J Gastroenterol; 2003 Dec; 9(12):2666-70. PubMed ID: 14669309 [TBL] [Abstract][Full Text] [Related]
14. Hepatic arterial infusion chemotherapy using high-dose 5-fluorouracil and cisplatin with or without interferon-alpha for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis. Eun JR; Lee HJ; Moon HJ; Kim TN; Kim JW; Chang JC Scand J Gastroenterol; 2009; 44(12):1477-86. PubMed ID: 19958061 [TBL] [Abstract][Full Text] [Related]
15. Systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis. Liu M; Shi J; Mou T; Wang Y; Wu Z; Shen A J Gastroenterol Hepatol; 2020 Aug; 35(8):1277-1287. PubMed ID: 32052876 [TBL] [Abstract][Full Text] [Related]
16. Comparison of hepatic arterial infusion chemotherapy versus sorafenib monotherapy in patients with advanced hepatocellular carcinoma. Kawaoka T; Aikata H; Hyogo H; Morio R; Morio K; Hatooka M; Fukuhara T; Kobayashi T; Naeshiro N; Miyaki D; Hiramatsu A; Imamura M; Kawakami Y; Takahashi S; Waki K; Tsuji K; Kohno H; Kohno H; Moriya T; Chayama K J Dig Dis; 2015 Sep; 16(9):505-12. PubMed ID: 26121102 [TBL] [Abstract][Full Text] [Related]
17. Pathological complete response by advanced hepatocellular carcinoma with massive macrovascular invasion to hepatic arterial infusion chemotherapy: a case report. Sano S; Nakata S; Wada S; Kuroiwa M; Sakai H; Kusama K; Machida T; Nishio A; Ito I; Sodeyama H World J Surg Oncol; 2019 Dec; 17(1):229. PubMed ID: 31878937 [TBL] [Abstract][Full Text] [Related]
18. Hepatic artery infusion chemotherapy combined with camrelizumab plus rivoceranib for hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter propensity score-matching analysis. Li Y; Guo J; Liu W; Pang H; Song Y; Wu S; Zhang F; Yan D; Chen J; An C; Li C Hepatol Int; 2024 Aug; 18(4):1286-1298. PubMed ID: 38717693 [TBL] [Abstract][Full Text] [Related]
19. Hepatic arterial infusion chemotherapy in the treatment of advanced hepatocellular carcinoma with portal vein thrombosis: a case-control study. Abdelmaksoud AHK; Abdelaziz AO; Nabeel MM; Hamza I; Elbaz TM; Shousha HI; Abdelhady RSM; Lithy R Clin Radiol; 2021 Sep; 76(9):709.e1-709.e6. PubMed ID: 34116796 [TBL] [Abstract][Full Text] [Related]
20. Comparison of Outcome of Hepatic Arterial Infusion Chemotherapy and Sorafenib in Patients with Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization. Hatooka M; Kawaoka T; Aikata H; Morio K; Kobayashi T; Hiramatsu A; Imamura M; Kawakami Y; Murakami E; Waki K; Honda Y; Mori N; Takaki S; Tsuji K; Kohno H; Kohno H; Moriya T; Nonaka M; Hyogo H; Aisaka Y; Chayama K Anticancer Res; 2016 Jul; 36(7):3523-9. PubMed ID: 27354618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]